vs
Marker Therapeutics, Inc.（MRKR）与Rigetti Computing, Inc.（RGTI）财务数据对比。点击上方公司名可切换其他公司
Rigetti Computing, Inc.的季度营收约是Marker Therapeutics, Inc.的1.7倍（$1.9M vs $1.1M），Marker Therapeutics, Inc.净利率更高（-154.4% vs -974.7%，领先820.3%），Rigetti Computing, Inc.同比增速更快（-17.9% vs -51.0%），过去两年Marker Therapeutics, Inc.的营收复合增速更高（-5.8% vs -21.8%）
Marker Therapeutics是一家临床阶段生物技术企业，专注于开发用于癌症治疗的创新T细胞免疫疗法，产品管线覆盖血液恶性肿瘤及多种实体瘤，主要面向美国肿瘤治疗市场，致力于满足患者的未竟医疗需求。
Rigetti Computing总部位于美国加利福尼亚州伯克利，是专业的超导量子集成电路研发商，产品主要应用于量子计算机领域。公司还推出了名为Forest的云平台，支持开发者编写各类量子算法。
MRKR vs RGTI — 直观对比
营收规模更大
RGTI
是对方的1.7倍
$1.1M
营收增速更快
RGTI
高出33.1%
-51.0%
净利率更高
MRKR
高出820.3%
-974.7%
两年增速更快
MRKR
近两年复合增速
-21.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1M | $1.9M |
| 净利润 | $-1.7M | $-18.2M |
| 毛利率 | — | 34.9% |
| 营业利润率 | -170.7% | -1209.7% |
| 净利率 | -154.4% | -974.7% |
| 营收同比 | -51.0% | -17.9% |
| 净利润同比 | 55.6% | 88.1% |
| 每股收益（稀释后） | $0.02 | $-0.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MRKRRGTI
| Q4 25 | $1.1M | $1.9M | ||
| Q3 25 | $1.2M | $1.9M | ||
| Q2 25 | $861.2K | $1.8M | ||
| Q1 25 | $349.1K | $1.5M | ||
| Q4 24 | $2.3M | $2.3M | ||
| Q3 24 | $1.9M | $2.4M | ||
| Q2 24 | $1.2M | $3.1M | ||
| Q1 24 | $1.2M | $3.1M |
净利润MRKRRGTI
| Q4 25 | $-1.7M | $-18.2M | ||
| Q3 25 | $-2.0M | $-201.0M | ||
| Q2 25 | $-4.0M | $-39.7M | ||
| Q1 25 | $-4.4M | $42.6M | ||
| Q4 24 | $-3.8M | $-153.0M | ||
| Q3 24 | $-2.3M | $-14.8M | ||
| Q2 24 | $-2.2M | $-12.4M | ||
| Q1 24 | $-2.4M | $-20.8M |
毛利率MRKRRGTI
| Q4 25 | — | 34.9% | ||
| Q3 25 | — | 20.7% | ||
| Q2 25 | — | 31.4% | ||
| Q1 25 | — | 30.0% | ||
| Q4 24 | — | 44.1% | ||
| Q3 24 | — | 50.6% | ||
| Q2 24 | — | 64.5% | ||
| Q1 24 | — | 49.1% |
营业利润率MRKRRGTI
| Q4 25 | -170.7% | -1209.7% | ||
| Q3 25 | -173.3% | -1055.4% | ||
| Q2 25 | -494.8% | -1103.9% | ||
| Q1 25 | -1320.1% | -1469.6% | ||
| Q4 24 | -171.5% | -813.3% | ||
| Q3 24 | -124.6% | -729.4% | ||
| Q2 24 | -197.4% | -521.2% | ||
| Q1 24 | -204.9% | -543.4% |
净利率MRKRRGTI
| Q4 25 | -154.4% | -974.7% | ||
| Q3 25 | -162.1% | -10321.9% | ||
| Q2 25 | -466.3% | -2201.8% | ||
| Q1 25 | -1273.6% | 2895.3% | ||
| Q4 24 | -170.4% | -6726.5% | ||
| Q3 24 | -119.8% | -623.8% | ||
| Q2 24 | -187.5% | -402.5% | ||
| Q1 24 | -192.3% | -680.6% |
每股收益（稀释后）MRKRRGTI
| Q4 25 | $0.02 | $-0.08 | ||
| Q3 25 | $-0.12 | $-0.62 | ||
| Q2 25 | $-0.29 | $-0.13 | ||
| Q1 25 | $-0.40 | $0.13 | ||
| Q4 24 | $-0.41 | $-0.80 | ||
| Q3 24 | $-0.26 | $-0.08 | ||
| Q2 24 | $-0.25 | $-0.07 | ||
| Q1 24 | $-0.27 | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $16.1M | $44.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $16.8M | $546.2M |
| 总资产 | $19.1M | $666.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资MRKRRGTI
| Q4 25 | $16.1M | $44.9M | ||
| Q3 25 | $17.6M | $26.1M | ||
| Q2 25 | $10.5M | $57.2M | ||
| Q1 25 | $13.7M | $37.2M | ||
| Q4 24 | $19.2M | $67.7M | ||
| Q3 24 | $9.0M | $20.3M | ||
| Q2 24 | $7.8M | $20.7M | ||
| Q1 24 | $11.3M | $35.1M |
股东权益MRKRRGTI
| Q4 25 | $16.8M | $546.2M | ||
| Q3 25 | $18.4M | $371.8M | ||
| Q2 25 | $10.5M | $553.3M | ||
| Q1 25 | $14.5M | $207.1M | ||
| Q4 24 | $18.6M | $126.6M | ||
| Q3 24 | $7.4M | $122.8M | ||
| Q2 24 | $9.7M | $122.2M | ||
| Q1 24 | $11.8M | $115.6M |
总资产MRKRRGTI
| Q4 25 | $19.1M | $666.6M | ||
| Q3 25 | $21.7M | $630.3M | ||
| Q2 25 | $14.8M | $636.7M | ||
| Q1 25 | $17.0M | $269.1M | ||
| Q4 24 | $22.0M | $284.8M | ||
| Q3 24 | $10.9M | $157.3M | ||
| Q2 24 | $11.7M | $162.4M | ||
| Q1 24 | $14.1M | $162.1M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.9M | $-14.9M |
| 自由现金流经营现金流 - 资本支出 | — | $-19.5M |
| 自由现金流率自由现金流/营收 | — | -1042.5% |
| 资本支出强度资本支出/营收 | — | 244.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-77.2M |
8季度趋势，按日历期对齐
经营现金流MRKRRGTI
| Q4 25 | $-1.9M | $-14.9M | ||
| Q3 25 | $-2.7M | $-13.8M | ||
| Q2 25 | $-1.9M | $-16.2M | ||
| Q1 25 | $-5.5M | $-13.7M | ||
| Q4 24 | $-4.7M | $-8.5M | ||
| Q3 24 | $1.2M | $-15.4M | ||
| Q2 24 | $-3.6M | $-13.5M | ||
| Q1 24 | $-3.8M | $-13.1M |
自由现金流MRKRRGTI
| Q4 25 | — | $-19.5M | ||
| Q3 25 | — | $-19.7M | ||
| Q2 25 | — | $-21.8M | ||
| Q1 25 | — | $-16.2M | ||
| Q4 24 | — | $-9.8M | ||
| Q3 24 | — | $-17.7M | ||
| Q2 24 | — | $-15.6M | ||
| Q1 24 | — | $-18.6M |
自由现金流率MRKRRGTI
| Q4 25 | — | -1042.5% | ||
| Q3 25 | — | -1012.4% | ||
| Q2 25 | — | -1212.4% | ||
| Q1 25 | — | -1100.4% | ||
| Q4 24 | — | -432.1% | ||
| Q3 24 | — | -744.5% | ||
| Q2 24 | — | -504.3% | ||
| Q1 24 | — | -610.5% |
资本支出强度MRKRRGTI
| Q4 25 | — | 244.8% | ||
| Q3 25 | — | 302.5% | ||
| Q2 25 | — | 314.7% | ||
| Q1 25 | — | 173.0% | ||
| Q4 24 | — | 56.4% | ||
| Q3 24 | — | 95.8% | ||
| Q2 24 | — | 66.3% | ||
| Q1 24 | — | 180.0% |
现金转化率MRKRRGTI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.32× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MRKR
暂无分部数据
RGTI
| Collaborative Research And Other Professional Services | $1.7M | 93% |
| Other | $131.0K | 7% |
